openPR Logo

Press Releases by Category Business, Economy, Finances, Banking & Insurance

RSS-Newsfeed

Vitrectomy Devices Market Intelligence Report: Global Forecast, Regulatory Shift …

DelveInsight projects the Vitrectomy Devices market, valued at USD 1.12B in 2023, to grow at 7.12% CAGR through 2030, driven by rising retinal disorders and AI-enabled systems. Key players include Alcon, Carl Zeiss Meditec AG, Leica Microsystems, IRIDEX, Lumenis, NIDEK, D.O.R.C., Geuder, Optos, Hoya Surgical Optics, BVI, and Johnson & Johnson. North America leads, with regulatory shifts (QMSR) reshaping manufacturers' strategies. Key Takeaways * Market size projection: As per DelveInsight's analysis, the

Obesity Treatment Landscape: Teva Launches First Generic GLP-1 Weight Loss Drug …

DelveInsight Business Research's latest report highlights the transformative impact of Teva Pharmaceuticals' FDA approval and U.S. launch of the first-ever generic GLP-1 product specifically indicated for weight loss. This landmark approval of generic Saxenda (liraglutide injection) marks a paradigm shift in the obesity treatment market, offering new hope for millions of patients who previously couldn't afford branded GLP-1 therapies in a market projected to reach unprecedented heights. Key Obesity Market Highlights

Immune Thrombocytopenia Treatment Landscape: FDA Approves WAYRILZ, First BTK Inh …

DelveInsight Business Research's latest report highlights the transformative impact of the FDA's approval of WAYRILZ (rilzabrutinib) by Sanofi (Euronext: SAN, NASDAQ: SNY). This landmark approval marks the first BTK inhibitor approved for immune thrombocytopenia (ITP), offering new hope for over 120K patients suffering from this complex autoimmune disorder (in the US alone) characterized by dangerously low platelet counts and increased bleeding risk. Key Immune Thrombocytopenia Market Highlights * WAYRILZ's approval is expected

Alzheimer's Disease Treatment: FDA Approves LEQEMBI IQLIK, First Self-Administer …

DelveInsight's latest report highlights the transformative impact of the FDA's approval of LEQEMBI IQLIK by Eisai Co. and Biogen Inc. (NASDAQ: BIIB). This landmark approval marks the first-ever at-home, self-administered treatment option for ongoing Alzheimer's disease, offering unprecedented convenience and accessibility for over 16 million patients suffering from this progressive neurodegenerative disorder characterized by amyloid-beta plaque accumulation and cognitive decline. Key Alzheimer's Disease Market Highlights * LEQEMBI IQLIK FDA approval is expected

Drug Delivery Devices Market Size, Trends, and Strategic Opportunities Through 2 …

DelveInsight projects the global Drug Delivery Devices market to grow at a 7.90% CAGR through 2030, driven by rising chronic diseases and innovation in injectables, inhalers, implants, and patches. Key players include Pfizer, Johnson & Johnson, Roche, Novartis, 3M, Bayer, Boehringer Ingelheim, and Medtronic. Oncology, diabetes, and respiratory diseases fuel demand, with FDA's QMSR set to impact manufacturers by 2026. Key Takeaways * Market size projection: As per DelveInsight's analysis, the total

With Affordable Payroll Services from IBN Technologies U.S. Firms Maintain Cost- …

IBN Technologies delivers affordable payroll services designed for U.S. small businesses seeking accuracy, compliance, and cost-efficiency. With cloud-based systems, encrypted data security, and expert support, firm streamlines payroll, tax reporting & employee classification. Firms save money, reduce errors, and scale confidently while staying aligned with evolving labor regulations. Miami, Florida - 02 Sep, 2025 - For small business owners in the United States who want better accuracy and cost control, payroll

Critical Limb Ischemia Market Outlook 2034 - Clinical Trials, Market Size, Medic …

Critical Limb Ischemia companies are Boston Scientific Corporation, AnGes, Inc., Mitsubishi Tanabe Pharma, B. Braun Melsungen AG, Medtronic Endovascular, Ixaka Ltd, Mercator MedSystems, Inc, Hemostemix Inc., Caladrius Biosciences, Reven Pharmaceuticals, Inc., New Beta Innovation Limited, BioGenCell, Abbott, and others Critical Limb Ischemia Market Summary According to DelveInsight, there were about 2.44 million diagnosed cases of Critical Limb Ischemia (CLI) in the 7MM in 2023, a number projected to rise by 2034. The

Cholangiocarcinoma Market Outlook 2034 - Clinical Trials, Market Size, Medicatio …

Cholangiocarcinoma companies are AstraZeneca, Decalth Systems, Power Life Sciences, Genfit, Servier Affaires Medicales, Basilea Pharmaceutica, Taiho Oncology, Eisai Pharmaceuticals, TransThera Sciences, Incyte Corporation, Roche, Agios Pharmaceuticals, Servier Pharmaceuticals, and Others. Cholangiocarcinoma Market Summary The Cholangiocarcinoma market remains dominated by chemotherapy, though targeted and immunotherapies are emerging. In 2023, the U.S. accounted for the largest market share among the 7MM (~45,000 cases, with ~45% intrahepatic). The disease is more common in older populations,

Soft Tissue Sarcoma Clinical Trial Assessment 2025: Investigational Drugs, FDA A …

Soft Tissue Sarcoma companies working in the treatment market are Advenchen Laboratories, Philogen, Gradalis, Epizyme, Taiho Pharmaceuticals, KaryoPharm Therapeutics, Nanobiotix, Incyte Corporation, AVEO Pharmaceuticals, Bayer, Mirati Therapeutics, Novartis, Incyte, Exelixis, Qbiotics, AstraZeneca, Loxo Oncology, ImmunityBio, Monopar Therapeutics, Chipscreen Biosciences, Agenus, Cornerstone Pharmaceuticals, Takara Bio, Jazz Pharmaceuticals, Lyell Immunopharma, Telix Pharmaceuticals and others. (Albany, United States) According to DelveInsight, the global Soft Tissue Sarcoma pipeline includes 125+ companies actively developing over 130

NSCLC Clinical Trials Assessment 2025: Therapeutics Landscape, FDA Approvals, Pi …

NSCLC Companies working in the market include BridgeBio Pharma, Daiichi Sankyo, EMD Serono/Merck, BridgeBio Pharma, Abbvie/Pfizer, Eli Lilly, BioNTech SE, Shenzhen TargetRx, Taiho Pharmaceutical, Chong Kun Dang, Bristol Myers Squibb, Innovent Biologics, Bayer, GeneScience Pharmaceuticals, InventisBio, Apollomics, Imugene, Ono Pharmaceutical/Pierre Fabre,Surface Oncology, Inhibrx, Sinocelltech, Mirati Therapeutics, REVOLUTION Medicines, Iovance Biotherapeutics, Galecto Biotech, and others. Non-Small Cell Lung Cancer Clinical Trial Summary The NSCLC pipeline is highly active, with 135+ companies developing 150+

Chronic Inflammatory Demyelinating Polyneuropathy Market Outlook 2034 - Clinical …

CIDP Companies are Takeda, Argenx, Sanofi, Janssen Research and Development, Immunovant Sciences GmbH, HanAll Pharma, Roivant Sciences, Shire, Argenx, Sanofi, Nihon Pharmaceutical, Immunovant Sciences, Octapharma, CSL Behring, Janssen Research, Novartis, Biogen, UCB Biopharma, Takeda, MedDay Pharmaceuticals, Teijin Pharma, Pfizer, Octapharma, Momenta Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Kedrion, Grifols, Bio Products Laboratory, Baxter, GeNeuro Pharmaceuticals, and others Chronic Inflammatory Demyelinating Polyneuropathy Market Summary The Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) market is set to

Hepatocellular Carcinoma Clinical Trials Assessment 2025: Competitive Landscape, …

Hepatocellular Carcinoma companies are Polaris Pharmaceuticals, Sumitomo Pharma, Surface Oncology, Oxford BioTherapeutics, OriCell Therapeutics, Tarus Therapeutics, Tvardi Therapeutics, SCG Cell Therapy, AVEO Oncology, Sinocelltech, GlaxoSmithKline, Iterion Therapeutics, Array BioPharma, Beijing SyngenTech, Antengene Corporation, Shenogen Pharma, Novartis Oncology, Eutilex, SillaJen Biotherapeutics, Guangdong ProCap Zoom Biosciences, and Chugai Pharmaceutical. (Albany, USA) According to DelveInsight's analysis, the Hepatocellular Carcinoma (HCC) pipeline Report comprises over 90+ companies developing more than 95+ drug candidates across diverse

AI in Environmental Sustainability Market to Reach USD 63.5 Million by 2031 at 2 …

Artificial Intelligence has moved from pilot projects to large-scale deployment across the environmental sector, powering breakthroughs in renewable energy optimization, disaster forecasting, emissions intelligence, and sustainable supply chains. Building on the latest industry analysis "AI In Environmental Sustainability - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" from QYResearch, this release highlights market data, company achievements, and 2025 trends shaping the global landscape. Latest Data • Market size in 2024:

Seasoned Payroll Service Providers IBN Technologies Boost Efficiency for US Ente …

IBN Technologies delivers scalable payroll outsourcing services that streamline compliance, enhance data security, and cut costs for U.S. enterprises. With cloud-based access, expert tax compliance, and 24/5 support, their tailored payroll solutions ensure accuracy and efficiency. Businesses partner with IBN to reduce risks, improve operations, and focus on sustainable growth. Miami, Florida - 02 Sep, 2025 - As USA's business environment becomes increasingly intricate due to evolving tax laws and labor

IBN Technologies' Remote Bookkeeping Services Help US Healthcare Firms Stay Cost …

IBN Technologies delivers remote bookkeeping services tailored to U.S. healthcare providers, helping manage patient billing, reimbursements, and vendor payments while ensuring HIPAA compliance. With 26+ years of experience, IBN enables clinics and hospitals to reduce costs, improve audit readiness, and gain financial clarity through secure, cloud-based solutions. Miami, Florida - 02 Sep, 2025 - The U.S. healthcare industry continues to face financial strain due to rising expenses, personnel shortages, and reimbursement

DTFU Logistics Releases 2025 Guide: Shipping from China to USA

DTFU Logistics' 2025 press guide to Shipping from China to USA explains sea vs. air vs. doortodoor options, key China/US ports, typical transit times (ocean 12-18 days to West Coast, 28-40 to East Coast; air 1-5 days terminaltoterminal), and cost factors so importers can budget accurately and plan inventory with confidence-backed by endtoend solutions from DTFU Logistics. Shenzhen, China - DTFU Logistics today released a practical, plainEnglish guide to help importers

TCR Therapy Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approv …

DelveInsight's "TCR Therapy Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the TCR Therapy pipeline landscape. It covers the TCR Therapy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the TCR Therapy therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment

Polycythemia Vera Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA …

DelveInsight's, "Polycythemia Vera Pipeline Insight 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Polycythemia Vera pipeline landscape. It covers the Polycythemia Vera pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Polycythemia Vera therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options

COVID-19 Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals …

DelveInsight's, "COVID-19 Pipeline Insight 2025" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in COVID-19 pipeline landscape. It covers the COVID-19 pipeline drug profiles, including clinical and nonclinical stage products. It also covers the COVID-19 therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options in the COVID-19 Pipeline.

Familial Mediterranean Fever Pipeline Outlook 2025: Clinical Trial Studies, EMA, …

DelveInsight's "Familial Mediterranean Fever Pipeline Insight 2025" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Familial Mediterranean Fever pipeline landscape. It covers the Familial Mediterranean Fever pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Familial Mediterranean Fever therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the

Alzheimer's Disease Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FD …

DelveInsight's, "Alzheimer's Disease Pipeline Insight 2025" report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Alzheimer's disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options in the Alzheimer's Disease

CryptoMiningFirm Launches First XRP, BTC Mobile App: Earn Huge Rewards of at Lea …

Massachusetts, 2nd September 2025, ZEX PR WIRE- CryptoMiningFirm has officially presented an innovative mobile app that has enabled it to make earning through cryptocurrency easier, faster and more lucrative than ever before. The app, which is geared to provide at least 17,067 daily rewards, is attracting huge investor interest across the globe. Its smooth interface, powerful features, and clear rewards, it is not merely a tool, but an entire wealth-building

High-Grade Glioma Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA …

DelveInsight's, "High-Grade Glioma Pipeline Insight 2025" report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in High-Grade Glioma pipeline landscape. It covers the High-Grade Glioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the High-Grade Glioma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in High-Grade

Non Cystic Fibrosis Bronchiectasis Pipeline Drugs 2025: Clinical Trial Studies, …

DelveInsight's, "Noncystic fibrosis bronchiectasis Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Noncystic fibrosis bronchiectasis pipeline landscape. It covers the Non Cystic Fibrosis Bronchiectasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Cystic Fibrosis Bronchiectasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this

Melanoma Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals …

DelveInsight's "Melanoma Pipeline Insights 2025" report provides comprehensive insights about 150+ companies and 170+ pipeline drugs in the Melanoma Pipeline landscape. It covers the Melanoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Melanoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Melanoma research. Learn more

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …

A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd. Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the

Squamous Cell Carcinoma Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA …

DelveInsight's, "Squamous Cell Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Squamous Cell Carcinoma pipeline landscape. It covers the Squamous Cell Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Squamous Cell Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive

Bronchopulmonary Dysplasia Pipeline Outlook 2025: Clinical Trial Studies, EMA, P …

DelveInsight's, "Bronchopulmonary Dysplasia Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Bronchopulmonary Dysplasia pipeline landscape. It covers the Bronchopulmonary Dysplasia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bronchopulmonary Dysplasia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Bronchopulmonary

Investigation announced for Long-Term Investors in shares of Red Cat Holdings, I …

An investigation was announced for current long-term investors in shares of Red Cat Holdings, Inc. (NASDAQ: RCAT) concerning potential breaches of fiduciary duties by certain directors of Red Cat Holdings, Inc. Investors who are current long term investors in Red Cat Holdings, Inc. (NASDAQ: RCAT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long

Lawsuit was filed for Investors who lost money with shares in CTO Realty Growth, …

An investor, who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO), filed a lawsuit over alleged violations of Federal Securities Laws by CTO Realty Growth, Inc. in connection with certain allegedly false and misleading statements made between February 18, 2021 and June 24, 2025. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and for certain investors are short and strict deadlines running. Deadline: October

Investigation announced for Long-Term Investors in shares of Fortrea Holdings In …

An investigation was announced for current long-term investors in shares of Fortrea Holdings Inc. (NASDAQ: FTRE) concerning potential breaches of fiduciary duties by certain directors of Fortrea Holdings Inc. Investors who are current long term investors in Fortrea Holdings Inc. (NASDAQ: FTRE) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors

AMR Battery Market to Reach USD 3935 Million by 2031 at 16.5% CAGR Driven by Ene …

The global Autonomous Mobile Robots (AMRs) Battery market continues its rapid expansion on the back of AI-enhanced robots, interoperable mixed fleets, and higher-power charging ecosystems. According to QYResearch new report "Global Autonomous Mobile Robots (AMRs) Battery Market Research Report 2025," the market was valued at US$1,321 million in 2024 and is projected to reach US$3,935 million by 2031 at a 16.5% CAGR (2025-2031). Production reached ~8,863 MWh in 2024 with

Lithium Battery Market for Agricultural Machinery to Reach USD 738 Million by 20 …

Global demand for lithium-ion batteries in agricultural machinery is accelerating as farms electrify tractors, harvesters and seeders. According to QYResearch report Global Agricultural Machinery Lithium Battery Market Outlook, In-Depth Analysis & Forecast to 2031, the market will grow from US$456 million in 2024 to US$738 million by 2031, registering a CAGR of 7.1% during 2025-2031. Global production reached approximately 2,871 MWh in 2024, with an average market price of US$159/kWh.

Automotive Composites Market Size, Market Share, Price and Growth Rate Research …

The automotive composites industry is gaining momentum as lightweight, durable, and sustainable materials become vital for modern mobility. Driven by rising EV adoption, fuel efficiency goals, and emission regulations, composites are increasingly used in structural and interior applications. Key players like Toray Industries, Hexcel, SGL Carbon, Teijin, and Gurit are driving innovation to meet evolving automotive needs. The automotive composites market is projected to grow from USD 9.69 billion in 2024

Generative AI Cybersecurity Market Recent Trends, Outlook, Size, Share, Top Comp …

Generative AI Cybersecurity Market by Generative AI-based Cybersecurity (SIEM, Risk Assessment, Threat Intelligence), Cybersecurity Software for Generative AI (AI Model Security), Security Type (Data Encryption, Access Control) - Global Forecast to 2031. The Generative AI Cybersecurity Market [https://www.marketsandmarkets.com/Market-Reports/generative-ai-cybersecurity-market-164202814.html?utm_campaign=generativeaicybersecuritymarket&utm_source=abnewswire.com&utm_medium=paidpr] is expected to develop at a compound annual growth rate (CAGR) of 26.5% during the forecast period, from an estimated USD 8.65 billion in 2025 to USD 35.50 billion by 2031. The sharp

Water Recycle and Reuse Market Size, Market Share, Industry Analysis Report 2025 …

The Water Recycle and Reuse industry is gaining momentum as rising water scarcity and stricter regulations drive adoption across municipal, industrial, and agricultural sectors. Companies are innovating advanced treatment technologies to improve efficiency and sustainability. With growing global emphasis on circular water management, leading players are well-positioned to capture expanding opportunities. The water recycle and reuse market size is projected to grow from USD 17.89 billion in 2025 to USD 29.61

Colorado Medical Practice Reports Breakthrough Wellness Outcomes Using Enhanced …

Weight Loss NP, LLC reports significant patient wellness improvements through specialized treatment protocols combining advanced medications with personalized telemedicine care across Colorado, Utah, and Florida markets. Weight Loss NP, LLC, a Colorado-based medical practice, has documented significant patient success rates through specialized treatment protocols that have transformed healthcare delivery across three states. The practice's comprehensive approach to medical wellness management has shown measurable improvements in patient outcomes through telemedicine services spanning

Investor Spotlight: PNPNF, CARM, RAYA, WAI, CYCU Mag Penny Undercard - More Stoc …

The micro-cap and penny stock arena continues to deliver high-risk, high-reward opportunities, with a dozen companies now gaining attention across the "Mag Penny Undercard" watch list. From emerging technology to biotech, energy, and resource exploration, these under-the-radar plays could be primed for outsized moves this fall. Carisma Therapeutics Inc. (NASDAQ: CARM) is advancing cell therapy innovation with its proprietary CAR-M platform, which engineers' macrophages to fight solid tumors. Early clinical data

Body Balance Massage and Float Expands Therapeutic Massage in Pleasant Grove wit …

Body Balance Massage and Float is expanding with a new facility to meet growing demand for pain management. The expansion includes an anti-claustrophobic float therapy center with open pools, enhancing their massage services in Lehi and Pleasant Grove for more inclusive wellness options. Body Balance Massage and Float announces the expansion of therapeutic services with a specialized facility designed to address the growing demand for professional pain management solutions. The expansion

Office Movers in Portland Gain Certified Carbon Neutral Status as Redefyne Movin …

Redefyne Moving & Storage in Portland, OR, is the first office mover to achieve certified carbon-neutral status. The company is launching a green business initiative to lead eco-friendly commercial relocations in the region. PORTLAND, OR - Redefyne Moving & Storage has achieved certified carbon neutral status, becoming the first office movers in Portland [https://maps.google.com/maps?ll=45.518939,-122.662055&z=16&t=m&hl=en&gl=US&mapclient=embed&cid=3666043436181662536&q=movers+portland&oq=moving+company] to earn this environmental distinction. The company is launching a comprehensive green business initiative aimed at transforming

Chip Skinner Calls for More Everyday Leaders in Local Government and Youth Sport …

Image: https://www.globalnewslines.com/uploads/2025/09/1756814741.jpg Chip Skinner, Gainesville, FL. GRUA Board Director and Coach Urges Public to Step In Where Systems Fall Short Following his recent in-depth interview "Clear Talk and Quiet Impact: A Conversation with Chip Skinner," longtime consultant, coach, and Gainesville Regional Utilities Authority (GRUA) board member Chip Skinner is raising awareness around two growing issues: the lack of community involvement in local utility oversight and the decline of mentorship opportunities for youth. "There's this

Press Earth Is Changing the Game in Global PR

Image: https://www.globalnewslines.com/uploads/2025/09/1756745317.jpg Press Earth unveils a global PR platform that accelerates media communications and empowers brands with visibility and credibility. In an era where a brand's reputation can be shaped by just a few headlines, a new platform is radically transforming the global public relations landscape. Press Earth has unveiled its innovative model, guaranteeing brands placement in the world's most prestigious and trusted media outlets, directly addressing the core challenges that traditional

British Children's Book Making Science Magical Reaches #1 on Amazon in US and UK

Image: https://www.globalnewslines.com/uploads/2025/09/1756810749.jpg Bertie Stephens [centre], CEO of Clean Planet Foundation: "Science can be every bit as magical as fantasy." A British children's book that blends science and fantasy has climbed to #1 on Amazon in both the US and UK - being hailed as a bold new kind of children's fiction, Ellie Ment and the Material Matter [https://www.elliement.com/] is inspiring thousands of young readers on both sides of the Atlantic. And its

Risen Energy's HJT Hyper-ion Modules Drive Over 2 Million Yuan in Power Station …

Recently, Risen Energy's HJT Hyper-ion modules have delivered ultra-high power generation performance at the 7.767MWp photovoltaic power station in Ludongye Dong Village, Jiaoyu Town, Daiyue District, Tai'an City, Shandong Province, earning widespread acclaim. As of July 31, 2025, the station's cumulative power generation has exceeded 7.92 million kWh, directly generating 2.8 million yuan in electricity revenue. The HJT project spans approximately 9.73 hectares and was connected to the grid in December

The Salt Sculpture Exhibition has officially opened on August 16 at the 2025 Sal …

The "2025 Salt Sculpture and Light Sculpture Art Festival", hosted by the Southwest Coast National Scenic Area Headquarters of the Tourism Administration of the Ministry of Transportation and Communications (here referred to as the Southwest Coast National Scenic Area Headquarters), grandly opened on August 16 at the Qigu Salt Mountain in Tainan, presenting Taiwan's only summer art festival integrating salt sculpture and light sculpture. This year, the popular LINE sticker,

ArtOptimizer for Adobe Illustrator Now Supports macOS Tahoe

Zevrix Solutions announces the release of ArtOptimizer 3.1.22, a compatibility upgrade to company's image processing workflow automation tool for Adobe Illustrator. ArtOptimizer helps users reduce the size of Illustrator links and automate complex image transformations. The software also offers image profile and format conversion, batch processing of Illustrator files, settings presets and much more. The new version adds support for the upcoming macOS 26 Tahoe expected to be released this

Frost & Sullivan Hosts the 19th Global Growth, Innovation and Leadership Summit …

The 2025 19th Frost & Sullivan Global Growth, Innovation and Leadership Summit and the 4th New Investment Event, hosted by Frost & Sullivan and co-organized by LeadLeo, was successfully held at the Jing'an Shangri-La Hotel in Shanghai from August 27 to 28, 2025. With the theme of "Intelligence Initiates a New JourneyJointly Shaping Global Growth Engines", the Summit consists of an opening ceremony, eight parallel forums and a series of

Fibrodysplasia Ossificans Market to Experience Notable Growth in Forecast Span b …

The Key Fibrodysplasia Ossificans Progressiva Companies in the market include - Ipsen, Regeneron Pharmaceutical, Biocryst,, and others. The Fibrodysplasia Ossificans Progressiva market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Fibrodysplasia Ossificans Progressiva pipeline products will significantly revolutionize the Fibrodysplasia Ossificans Progressiva market dynamics. DelveInsight's "Fibrodysplasia Ossificans Progressiva Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of

Diabetic Macular Edema Pipeline 2025: MOA and ROA Insights, Clinical Trials Stat …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Macular Edema pipeline constitutes key companies continuously working towards developing Diabetic Macular Edema treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Diabetic Macular Edema Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/diabetic-macular-edema-dme-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Diabetic Macular Edema Market. The Diabetic Macular

Hotel Revenue Management System Market Rewriting Long Term Growth Story | RevCon …

HTF MI just released the Global Hotel Revenue Management System Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2031. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major companies in Hotel Revenue Management System Market are:

Go To Page     21558 21557 21556 21555 21554 21553 21552 21551 21550 21549 17808 17807 17806 17805 17804 17803 17802 17801 17800 17799